跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
崔 克宏
教授
,
泌尿學科
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0003-1121-4402
電子郵件
t2130_
tmu.edu
tw
,
t2130
s.tmu.edu
tw
h-index
3802
引文
31
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1997 …
2024
每年研究成果
概覽
指紋
網路
專案
(7)
研究成果
(154)
類似的個人檔案
(6)
指紋
查看啟用 Ke-Hung Tsui 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Prostate Cancer
61%
Carcinoma Cell
57%
Prostate Carcinoma
48%
Prostate Specific Antigen
39%
Prostate Hypertrophy
37%
Transurethral Resection
37%
Bladder Cancer
33%
Bladder
31%
Bladder Carcinoma
28%
Neoplasm
28%
Prostatectomy
27%
Transrectal Ultrasonography
26%
Bleeding
23%
Enucleation
22%
International Prostate Symptom Score
21%
Androgen
21%
Cell Proliferation
21%
Lower Urinary Tract Symptom
20%
Clear Cell Renal Cell Carcinoma
19%
Metastatic Carcinoma
18%
Gene Expression
18%
Cell Invasion
17%
Thulium
17%
Cancer Cell
16%
Transitional Cell Carcinoma
16%
Partial Nephrectomy
15%
In Vitro
15%
Protein P53
15%
Androgen Receptor
15%
Symptom
15%
Caffeic Acid Phenethyl Ester
15%
Clinical Pathway
15%
Mucosa-Associated Lymphoid Tissue
15%
Radical Nephrectomy
14%
Computer Assisted Tomography
13%
Promoter Region
13%
Quality of Life
13%
down Regulation
12%
Needle Biopsy
12%
Operation Duration
11%
Urinary System
11%
Bladder Tumor
11%
Bladder Outlet Obstruction
11%
Survival Rate
11%
Aconitase
11%
Synapsin I
11%
Urinary Retention
11%
Signal Transduction
10%
Combination Therapy
10%
Cystectomy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Carcinoma
100%
Prostate Specific Antigen
52%
Bladder Carcinoma
45%
Prostate Cancer
37%
Androgen
34%
Protein P53
34%
Carcinogenesis
33%
Bladder Cancer
31%
Prostate Hypertrophy
25%
Androgen Receptor
24%
Western Blot
24%
Symptom
23%
Caffeic Acid Phenethyl Ester
22%
Interleukin 6
21%
Lower Urinary Tract Symptom
19%
Malignant Neoplasm
19%
Aconitase
18%
Neoplasm
16%
Carcinoma
15%
Bladder Obstruction
11%
Growth Differentiation Factor 15
11%
Maspin
10%
Tumor Suppressor Protein
9%
Tumor Growth
9%
Hypoxia
8%
Bladder Tumor
8%
Curcumin
7%
Ulinastatin
7%
Metallothionein III
7%
Kidney Pelvis Carcinoma
7%
Nucleophosmin
7%
Tifenamil
7%
Chemotherapy
7%
Synapsin I
7%
Transitional Cell Carcinoma
7%
Tumor Marker
7%
Mouth Squamous Cell Carcinoma
6%
Mimosine
6%
Residual Urine
6%
Doxorubicin
6%
Cohort Study
5%
Cisplatin
5%
Tamsulosin
5%
Camptothecin
5%
Urine Retention
5%
Adverse Event
5%
Mitogen Activated Protein Kinase
5%
Matriptase
5%
Thulium
5%
Combination Therapy
5%
Biochemistry, Genetics and Molecular Biology
Cell Proliferation
36%
Gene Expression
36%
Prostate-Specific Antigen
33%
LNCaP
29%
Carcinogenesis
23%
P53
23%
Aconitase
22%
Cancer Cell
22%
Cell Invasion
22%
Androgen Receptor
22%
Gene Translocation
20%
B Cell
20%
Antigen Expression
19%
N-Myc
18%
Western Blot
15%
Cell Growth
14%
Tumor Marker
14%
Promoter Region
13%
down Regulation
12%
Metallothionein
11%
WNT1
11%
Synapsin I
11%
Response Element
10%
Signal Transduction
10%
Upregulation
10%
Interleukin 6
9%
Urine Sampling
9%
Maspin
8%
Transient Expression
8%
Gene Expression Profiling
8%
Tumor Suppressor Gene
8%
Metabolomics
7%
Metabolite
7%
Growth Differentiation Factor
7%
Independent Pathway
7%
Proteomics
7%
Isobaric Tag for Relative and Absolute Quantitation
7%
Mucosa
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Restriction Fragment Length Polymorphism
6%
Proteome
6%
Single-Nucleotide Polymorphism
6%
DNA Synthesis
5%
Enzyme
5%
Plasminogen Activator
5%
Reverse Transcription Polymerase Chain Reaction
5%
Messenger RNA
5%
Stromal Cell
5%
Cancer Staging
5%
Genotyping
5%